| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10391 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPT1B mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10391 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPT1B mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10391 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CPT1B mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CPT1B mRNA | CTD | PMID:22298810 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CPT1B mRNA | CTD | PMID:21346803 |
| 4-nitroquinoline N-oxide | decreases expression | ISO | RGD:10391 | 6480464 | 4-Nitroquinoline-1-oxide results in decreased expression of CPT1B mRNA | CTD | PMID:22561872 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | multiple interactions | EXP | | 6480464 | AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B protein]; more ... | CTD | PMID:19699196 |
| all-trans-retinoic acid | increases expression | ISO | RGD:10391 | 6480464 | Tretinoin results in increased expression of CPT1B mRNA | CTD | PMID:16840543 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CPT1B mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:10391 | 6480464 | Benzo(a)pyrene results in increased expression of CPT1B mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10391 | 6480464 | Benzo(a)pyrene results in decreased expression of CPT1B mRNA | CTD | PMID:22610609 |
| beta-carotene | decreases expression | ISO | RGD:10391 | 6480464 | beta Carotene results in decreased expression of CPT1B mRNA | CTD | PMID:21569430 |
| bezafibrate | increases expression | ISO | RGD:10391 | 6480464 | Bezafibrate results in increased expression of CPT1B mRNA | CTD | PMID:11056218 PMID:21324916 |
| bezafibrate | increases expression | ISO | RGD:10391 | 6480464 | Bezafibrate results in increased expression of CPT1B mRNA | CTD | PMID:21324916 PMID:11056218 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of CPT1B mRNA | CTD | PMID:11473052 |
| bezafibrate | multiple interactions | ISO | RGD:10391 | 6480464 | PPARA protein affects the reaction [Bezafibrate results in increased expression of CPT1B mRNA] | CTD | PMID:21324916 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of CPT1B mRNA | CTD | PMID:22672789 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of CPT1B mRNA | CTD | PMID:18500788 |
| choline | multiple interactions | ISO | RGD:10391 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPT1B mRNA | CTD | PMID:20938992 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of CPT1B mRNA | CTD | PMID:12011481 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of CPT1B mRNA | CTD | PMID:12011481 PMID:12851107 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of CPT1B mRNA | CTD | PMID:12851107 PMID:12011481 |
| cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CPT1B mRNA | CTD | PMID:11549245 |
| copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CPT1B mRNA | CTD | PMID:17418555 |
| copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CPT1B mRNA | CTD | PMID:17418555 |
| diarsenic trioxide | decreases expression | ISO | RGD:619557 | 6480464 | arsenic trioxide results in decreased expression of CPT1B mRNA | CTD | PMID:22521957 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CPT1B mRNA | CTD | PMID:21266533 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CPT1B mRNA | CTD | PMID:18636392 |
| dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of CPT1B mRNA | CTD | PMID:18636392 |
| dioxygen | decreases expression | ISO | RGD:10391 | 6480464 | Oxygen deficiency results in decreased expression of CPT1B mRNA | CTD | PMID:21113404 |
| dioxygen | multiple interactions | ISO | RGD:10391 | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1B mRNA] | CTD | PMID:21113404 |
| fenofibrate | affects expression | EXP | | 6480464 | Fenofibrate affects the expression of CPT1B mRNA | CTD | PMID:20801182 |
| fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of CPT1B mRNA | CTD | PMID:19395589 |
| folic acid | multiple interactions | ISO | RGD:10391 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPT1B mRNA | CTD | PMID:20938992 |
| gemfibrozil | increases expression | EXP | | 6480464 | Gemfibrozil results in increased expression of CPT1B mRNA | CTD | PMID:12011481 |
| hydroxytyrosol | decreases expression | ISO | RGD:10391 | 6480464 | 3,4-dihydroxyphenylethanol results in decreased expression of CPT1B mRNA | CTD | PMID:21569430 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA | CTD | PMID:22129741 |
| L-methionine | multiple interactions | ISO | RGD:10391 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CPT1B mRNA | CTD | PMID:20938992 |
| methotrexate | decreases expression | ISO | RGD:10391 | 6480464 | Methotrexate results in decreased expression of CPT1B mRNA | CTD | PMID:18502557 |
| metoprolol | multiple interactions | EXP | | 6480464 | Metoprolol inhibits the reaction [MEF2A protein binds to CPT1B promoter]; more ... | CTD | PMID:19233164 |
| metoprolol | decreases expression | EXP | | 6480464 | Metoprolol results in decreased expression of CPT1B protein | CTD | PMID:19233164 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CPT1B mRNA | CTD | PMID:22129741 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CPT1B mRNA | CTD | PMID:18636392 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:10391 | 6480464 | perfluorooctane sulfonic acid results in increased expression of CPT1B mRNA | CTD | PMID:21705711 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of CPT1B mRNA | CTD | PMID:18692542 |
| perfluorooctanoic acid | increases expression | ISO | RGD:10391 | 6480464 | perfluorooctanoic acid results in increased expression of CPT1B mRNA | CTD | PMID:17681415 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of CPT1B mRNA | CTD | PMID:19162173 PMID:16221955 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of CPT1B mRNA | CTD | PMID:16221955 PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:10391 | 6480464 | Phenobarbital affects the expression of CPT1B mRNA | CTD | PMID:19136022 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CPT1B mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CPT1B mRNA | CTD | PMID:12011481 |
| phenylephrine | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine promotes the reaction [Phenylephrine results in decreased expression of CPT1B mRNA]; more ... | CTD | PMID:19699196 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of CPT1B mRNA | CTD | PMID:15721863 PMID:19699196 |
| phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of CPT1B mRNA | CTD | PMID:11879187 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of CPT1B protein | CTD | PMID:19699196 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of CPT1B mRNA | CTD | PMID:19699196 PMID:15721863 |
| phenylephrine | multiple interactions | EXP | | 6480464 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in decreased expression of CPT1B mRNA] | CTD | PMID:15721863 |
| pioglitazone | increases expression | ISO | RGD:10391 | 6480464 | pioglitazone results in increased expression of CPT1B mRNA | CTD | PMID:20723549 |
| pirinixic acid | multiple interactions | ISO | RGD:10391 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CPT1B mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:12011481 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:12011481 more ... |
| pirinixic acid | increases expression | ISO | RGD:10391 | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:17950772 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:18701451 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:18701451 more ... |
| pirinixic acid | increases expression | ISO | RGD:10391 | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:19162173 more ... |
| pirinixic acid | increases expression | ISO | RGD:10391 | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:19162173 more ... |
| pirinixic acid | multiple interactions | EXP | | 6480464 | RELA protein inhibits the reaction [pirinixic acid results in increased expression of CPT1B mRNA] | CTD | PMID:18701451 |
| pirinixic acid | multiple interactions | ISO | RGD:10391 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CPT1B mRNA] | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:10391 | 6480464 | pirinixic acid results in increased expression of CPT1B mRNA | CTD | PMID:17950772 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:10391 | 6480464 | [pirinixic acid co-treated with PPARA protein] results in increased expression of CPT1B mRNA | CTD | PMID:17275789 |
| pirinixic acid | affects expression | ISO | RGD:10391 | 6480464 | pirinixic acid affects the expression of CPT1B mRNA | CTD | PMID:19136022 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CPT1B mRNA | CTD | PMID:19162173 |
| quercetin | increases expression | ISO | RGD:619557 | 6480464 | Quercetin results in increased expression of CPT1B mRNA | CTD | PMID:21632981 |
| rosiglitazone | increases expression | ISO | RGD:10391 | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:15520860 PMID:20723549 |
| rosiglitazone | increases expression | ISO | RGD:10391 | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:15520860 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:10391 | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of CPT1B mRNA] | CTD | PMID:21113404 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:21515302 |
| rosiglitazone | increases expression | ISO | RGD:10391 | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:15520860 more ... |
| rosiglitazone | increases expression | ISO | RGD:10391 | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:20723549 more ... |
| rosiglitazone | affects expression | ISO | RGD:10391 | 6480464 | rosiglitazone affects the expression of CPT1B mRNA | CTD | PMID:22013433 |
| rosiglitazone | increases expression | ISO | RGD:10391 | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:22087241 more ... |
| rosiglitazone | increases expression | ISO | RGD:619557 | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:21559208 |
| rosiglitazone | multiple interactions | ISO | RGD:10391 | 6480464 | PPARGC1A affects the reaction [rosiglitazone results in increased expression of CPT1B mRNA] | CTD | PMID:22087241 |
| rosiglitazone | increases expression | ISO | RGD:10391 | 6480464 | rosiglitazone results in increased expression of CPT1B mRNA | CTD | PMID:22087241 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Dietary Fats results in decreased expression of CPT1B mRNA]; more ... | CTD | PMID:21034554 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [bexarotene co-treated with Tamoxifen] results in increased expression of CPT1B mRNA | CTD | PMID:17630414 |
| troglitazone | increases expression | ISO | RGD:10391 | 6480464 | troglitazone results in increased expression of CPT1B mRNA | CTD | PMID:12920214 |
| troglitazone | increases expression | ISO | RGD:619557 | 6480464 | troglitazone results in increased expression of CPT1B mRNA | CTD | PMID:12759900 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CPT1B mRNA | CTD | PMID:21515302 |